Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations.

[1]  J. Yewdell,et al.  Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Outflanking Antibody Immunodominance on the Road to Universal Influenza Vaccination. , 2018, Cold Spring Harbor perspectives in biology.

[2]  T. Kepler,et al.  Memory B Cells that Cross‐React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires , 2018, Immunity.

[3]  I. Wilson,et al.  A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus. , 2017, Journal of molecular biology.

[4]  A. Lanzavecchia,et al.  Tackling influenza with broadly neutralizing antibodies , 2017, Current Opinion in Virology.

[5]  Jonathan R. McDaniel,et al.  Potent and broad HIV-neutralizing antibodies in memory B cells and plasma , 2017, Science Immunology.

[6]  Nicole M. Bouvier,et al.  Defining the antibody cross-reactome against the influenza virus surface glycoproteins , 2017, Nature Immunology.

[7]  Matthew Angel,et al.  Defining B Cell Immunodominance to Viruses , 2017, Nature Immunology.

[8]  Baoshan Zhang,et al.  Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination , 2016, Nature Medicine.

[9]  S. Hensley,et al.  Antibodies with ‘Original Antigenic Sin’ Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses , 2016, PLoS pathogens.

[10]  Cinque S. Soto,et al.  Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses , 2016, Cell.

[11]  P. Collins,et al.  Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes , 2016, Cell.

[12]  K. Roskin,et al.  Defining antigen-specific plasmablast and memory B cell subsets in blood following viral infection and vaccination of humans , 2016, Nature Immunology.

[13]  James O. Lloyd-Smith,et al.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016, Science.

[14]  George Georgiou,et al.  Ultra-high-throughput sequencing of the immune receptor repertoire from millions of lymphocytes , 2016, Nature Protocols.

[15]  Jin Hyang Kim,et al.  Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains. , 2016, Vaccine.

[16]  T. Kepler,et al.  Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site. , 2015, Cell reports.

[17]  Adrian Apetri,et al.  A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen , 2015, Science.

[18]  J. Mascola,et al.  Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection , 2015, Nature Medicine.

[19]  T. Kepler,et al.  Viral Receptor-Binding Site Antibodies with Diverse Germline Origins , 2015, Cell.

[20]  D. Cummings,et al.  Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data , 2015, PLoS biology.

[21]  P. Palese,et al.  Advances in the development of influenza virus vaccines , 2015, Nature Reviews Drug Discovery.

[22]  George Georgiou,et al.  Next-generation sequencing and protein mass spectrometry for the comprehensive analysis of human cellular and serum antibody repertoires. , 2015, Current opinion in chemical biology.

[23]  Min Huang,et al.  High Preexisting Serological Antibody Levels Correlate with Diversification of the Influenza Vaccine Response , 2015, Journal of Virology.

[24]  George Georgiou,et al.  In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire , 2014, Nature Medicine.

[25]  Judith M. Fonville,et al.  Antibody landscapes after influenza virus infection or vaccination , 2014, Science.

[26]  Mark M. Davis,et al.  Distinct Patterns of B-Cell Activation and Priming by Natural Influenza Virus Infection Versus Inactivated Influenza Vaccination , 2014, The Journal of infectious diseases.

[27]  Qing Zhu,et al.  Rapid development of broadly influenza neutralizing antibodies through redundant mutations , 2014, Nature.

[28]  Y. Iba,et al.  Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus , 2014, Nature Communications.

[29]  Edward M. Marcotte,et al.  Proteomic Identification of Monoclonal Antibodies from Serum , 2014, Analytical chemistry.

[30]  Andrew D. Ellington,et al.  Identification and characterization of the constituent human serum antibodies elicited by vaccination , 2014, Proceedings of the National Academy of Sciences.

[31]  Damian C. Ekiert,et al.  Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin , 2013, Journal of Virology.

[32]  Antonio Lanzavecchia,et al.  Broadly neutralizing antiviral antibodies. , 2013, Annual review of immunology.

[33]  Jason J. Lavinder,et al.  Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response , 2013, Proceedings of the National Academy of Sciences.

[34]  John Steel,et al.  Cross-neutralization of influenza A viruses mediated by a single antibody loop , 2012, Nature.

[35]  Mark Mulligan,et al.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells , 2012, Proceedings of the National Academy of Sciences.

[36]  Andrew D. Ellington,et al.  Antibody Repertoires in Humanized NOD-scid-IL2Rγnull Mice and Human B Cells Reveals Human-Like Diversification and Tolerance Checkpoints in the Mouse , 2012, PloS one.

[37]  T. Kepler,et al.  H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination , 2011, PloS one.

[38]  J. Skehel,et al.  A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.

[39]  Surender Khurana,et al.  Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin , 2011, Proceedings of the National Academy of Sciences.

[40]  J. Yewdell,et al.  Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection , 2011, The Journal of experimental medicine.

[41]  G. Rimmelzwaan,et al.  Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands , 2011, Clinical and Vaccine Immunology.

[42]  Anthony S. Fauci,et al.  Influenza vaccines for the future. , 2010, The New England journal of medicine.

[43]  G. Nabel,et al.  Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination , 2010, Science.

[44]  K. Subbarao,et al.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. , 2010, The Journal of clinical investigation.

[45]  A. Falsey,et al.  Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. , 2010, Vaccine.

[46]  Ron A M Fouchier,et al.  Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.

[47]  D. Jarrossay,et al.  Clonal dissection of the human memory B‐cell repertoire following infection and vaccination , 2009, European journal of immunology.

[48]  Boguslaw Stec,et al.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses , 2009, Nature Structural &Molecular Biology.

[49]  Patrick C. Wilson,et al.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.

[50]  Andreas Zell,et al.  EDISA: extracting biclusters from multiple time-series of gene expression profiles , 2007, BMC Bioinformatics.

[51]  R. Weiss,et al.  A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies , 2007, Influenza and other respiratory viruses.

[52]  Paul G Thomas,et al.  Influenza and the challenge for immunology , 2006, Nature Immunology.

[53]  Antonio Lanzavecchia,et al.  Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.

[54]  A. Douglas,et al.  The evolution of human influenza viruses. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[55]  R. Ahmed,et al.  Humoral immunity due to long-lived plasma cells. , 1998, Immunity.

[56]  J. T. Curtis,et al.  An Ordination of the Upland Forest Communities of Southern Wisconsin , 1957 .

[57]  J. Aizpurua,et al.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016 .

[58]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.